
Pivagabine
CAS No. 69542-93-4
Pivagabine( CXB-722 )
Catalog No. M26382 CAS No. 69542-93-4
Pivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 42 | Get Quote |
![]() ![]() |
5MG | 68 | Get Quote |
![]() ![]() |
10MG | 115 | Get Quote |
![]() ![]() |
25MG | 237 | Get Quote |
![]() ![]() |
50MG | 348 | Get Quote |
![]() ![]() |
100MG | 518 | Get Quote |
![]() ![]() |
500MG | 1098 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamePivagabine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.
-
DescriptionPivagabine is a derivative of hydrophobic 4-aminobutyric acid, with neuromodulatory activity. Pivagabine penetrates the blood-brain barrier in rats. Pivagabine antagonizes the effects of foot shock on both GABAA receptor function and corticotropin-releasing factor (CRF) concentrations in rat brain.(In Vivo):Pivagabine (CXB 722) (200 mg/kg; i.p.; twice a day for 4 days and 1 hour before killing on the 5th day) prevents the effects of foot-shock stress on CRF concentration in both brain regions.
-
In Vitro——
-
In VivoPivagabine (CXB 722) (200 mg/kg; i.p.; twice a day for 4 days and 1 hour before killing on the 5th day) prevents the effects of foot-shock stress on CRF concentration in both brain regions. Animal Model:Adult male Sprague-Dawley CD rats (200-250 g)Dosage:200 mg/kg Administration:i.p.; twice a day for 4 days and 1 hour before killing on the 5th day Result:Prevented the effects of foot-shock stress on CRF concentration in both brain regions. Reduced by 52% the CRF concentration in the hypothalamus but had no effect on that in the cerebral cortex.
-
SynonymsCXB-722
-
PathwayOthers
-
TargetOther Targets
-
RecptorGlutamate receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number69542-93-4
-
Formula Weight187.239
-
Molecular FormulaC9H17NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (267.04 mM)
-
SMILESCC(C)(C)C(=O)NCCCC(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Andersson M, et, al. Inhibition of kainic acid binding to glutamate receptors by extracts of Gastrodia. Phytochemistry. 1995 Mar;38(4):835-6.
molnova catalog



related products
-
PH-064
PH-064 is a heterotrimeric G-protein complex inhibitor.
-
Procumbenoside E
The herbs of Sinopodophyllum hexandrum.
-
TAS1553
TAS1553 is a highly effective, orally bioavailable protein-protein interaction (PPI) inhibitor with an IC50 value of 0.0396 μM.